New Director of European Sales, Frank Raymakers, to Oversee Unit
MISSISSAUGA, ON, April 22 /CNW/ - MedX Health Corp., (TSXV.MDX) a global
leader in developing drug free, non-invasive low level laser and light therapy
for tissue repair and pain relief, today announced that the company has opened
a European Distribution Center located in the Netherlands. Following receipt
of the CE Mark approval to market and sell the family of MedX laser and light
products in all 25 European Union (EU) and three European Free Trade
Association Member (EFTA) states, MedX can now better serve its EU and EFTA
customers. In addition, MedX announced the appointment of Frank Raymakers as
Director of European Sales, to oversee operations.
Mecan b.v., a well established European medical device and supplies
distributor will be providing logistics and warehouse services for the MedX
European distribution center.
"We are very pleased to have been able to establish a distribution center
so quickly after receiving the CE Mark," states Steve Guillen, president and
CEO of MedX Health. "Having Frank on board will help us build a successful
medical device distribution network in Europe. MedX's European launch will be
one of the key drivers to our rapidly accelerating revenues in 2009."
As director, European Sales, Raymakers will build the network of EU
distributors in various countries for both the medical and dental markets. In
addition, he will be responsible for training and ongoing support for the MedX
EU distributor network.
Prior to joining MedX, Raymakers established a record of success in
building distribution networks with several medical device companies in
Europe. Most recently, he served as director of area and dealer management in
North-West Europe for EnviteC/Honeywell. Raymakers is a native of the
Netherlands and speaks fluent Dutch, German and English.
MedX Health is a global leader in the design, manufacturing and
distribution of quality low level laser and light therapy technology for use
in numerous medical settings that provide patients with non-invasive,
drug-free solutions for improving clinical outcomes. MedX's innovative
Laser/Light Therapy devices enhance the patient's quality of life and improve
the standard of care for tissue repair and pain relief.
MedX is expanding its distribution network and marketing programs
globally through strategic partnerships, while continuing to develop and
acquire new dental, rehabilitation and wound care products. In particular,
MedX plans to accelerate the development of a new product aimed at the
rapidly-growing wound care market. Recently, MedX announced a new patent
allowance for bone growth that will join several key existing patents,
including "Photobandage" a new technology that allows a wound to be bathed in
light and is designed to enhance the healing process. The Company intends to
license its proprietary wound care technologies to one or more major wound
care companies for further development, marketing and commercialization.
About Mecan b.v.
Mecan b.v. is a well established European medical device and supplies
distributor providing logistics and warehouse services for over 10 years for
product manufacturers in the human and veterinary markets, including Henry
Schein, Promhovet, S & B medvet, and Tecno-Gaz. Mecan provides the logistics,
sales, and financial services for more than 10,000 products, and stocks 1,500
different products in their facility in the Netherlands.
The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this press release.
This press release contains "forward-looking information" within the
meaning of applicable Canadian securities legislation. Such forward-looking
information may include statements regarding the Company's future plans,
objectives, performance, growth, profits, operating expenses or its underlying
assumptions. Generally, forward-looking information can be identified by the
use of forward-looking terminology such as "plans", "expects", or "does not
expect", "is expected", "budget", "scheduled", "estimates", "forecasts",
"intends", "anticipates", or "does not anticipate", or "believes" or
variations of such words and phrases or state that certain actions, events or
results "may", "could", "would", "might", or "will be taken", "occur", or "be
achieved". Forward-looking information is subject to known and unknown risks,
uncertainties and other factors that may cause the actual results, level of
activity, performance or achievements of MedX to be materially different from
those expressed or implied by such forward-looking information, including
uncertainty of successful development of new products, uncertainty of
successful manufacturing or marketing of products, uncertainty of commercial
acceptance of products, uncertainty concerning governmental regulation,
dependency on key employees and relationships, rapid technological changes,
foreign currency fluctuations. MedX does not undertake to update any
forward-looking information, except in accordance with applicable securities
For further information:
For further information: Investors: Steve Guillen, President and Chief
Executive Officer, MedX Health Corp., Phone: (905) 826-0766,
email@example.com; Media: Terri Clevenger, Continuum Health Communications,
Phone (203) 227-0209, Email: firstname.lastname@example.org; Europe: Frank
Raymakers, Director, European Sales, Direct: 0031-73-6576976, Cell:
0031-623-407058, Email: email@example.com